Showing results (1241-1250 of 2,672) with videos related to

Sort By:
Pageof 268
International Journal of Computer Assisted Radiology and Surgery|July 6, 2020
Combining visual analytics and case-based reasoning for rupture risk assessment of intracranial aneurysmsLena Spitz, Uli Niemann, Oliver Beuing, et al.
Lymphology|December 25, 2019
Bioimpedance spectroscopy is not associated with a clinical diagnosis of breast cancer-related lymphedemaJ A Spitz, Albert Chao, D M Peterson, et al.
Journal of Pediatric Surgery|June 1, 1989
Surgery, sepsis, and nonspecific immune function in neonatesN P Madden, R J Levinsky, R Bayston, et al.
Qualitative Health Research|June 29, 2018
Qualitative Methods Used to Generate Questionnaire Items: A Systematic ReviewLaetitia Ricci, Jean-Baptiste Lanfranchi, Fabienne Lemetayer, et al.
The American Journal of Medicine|May 1, 1985
Volatile nitrites. Use and adverse effects related to the current epidemic of the acquired immune deficiency syndromeG R Newell, P W Mansell, M R Spitz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 7, 1998
Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican- and African-AmericansN Ishibe, J K Wiencke, Z F Zuo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 1998
Reduced DNA repair capacity in head and neck cancer patientsL Cheng, S A Eicher, Z Guo, et al.
Plos Medicine|May 3, 2021
Sexual and reproductive health information and referrals for resettled refugee women: A survey of resettlement agencies in the United StatesTonya Katcher, Rebecca Thimmesch, Alison Spitz, et al.
Translational Oncology|December 4, 2025
The PI3K pathway is a downstream effector of NRF2 activation in the esophagusBoopathi Subramaniyan, Yahui Li, Zhaohui Xiong, et al.
Medical Mycology|April 3, 2024
Safety and pharmacokinetics of antifungal agent VT-1598 and its primary metabolite, VT-11134, in healthy adult subjects: phase 1, first-in-human, randomized, double-blind, placebo-controlled study of single-ascending oral doses of VT-1598Kenan Gu, Robert Spitz, Erin Hammett, et al.
Pageof 268